Ironwood Investment Counsel’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$295K Hold
588
0.04% 221
2026
Q1
$289K Sell
588
-17
-3% -$9.23K 0.04% 223
2025
Q4
$351K Buy
605
+17
+3% +$9.61K 0.05% 203
2025
Q3
$285K Buy
588
+14
+2% +$6.52K 0.04% 221
2025
Q2
$233K Sell
574
-7
-1% -$2.93K 0.04% 229
2025
Q1
$289K Buy
581
+33
+6% +$17.9K 0.05% 199
2024
Q4
$285K Hold
548
0.05% 211
2024
Q3
$339K Hold
548
0.06% 198
2024
Q2
$303K Hold
548
0.05% 211
2024
Q1
$319K Hold
548
0.06% 204
2023
Q4
$291K Sell
548
-65
-11% -$31.5K 0.05% 205
2023
Q3
$310K Buy
613
+5
+0.8% +$2.66K 0.07% 192
2023
Q2
$317K Sell
608
-215
-26% -$116K 0.07% 168
2023
Q1
$474K Buy
+823
New +$464K 0.11% 132
2022
Q1
Sell
-310
Closed -$207K 225
2021
Q4
$207K Buy
+310
New +$194K 0.05% 202
2021
Q1
Sell
-671
Closed -$312K 219
2020
Q4
$312K Hold
671
0.07% 167
2020
Q3
$296K Hold
671
0.08% 160
2020
Q2
$243K Buy
+671
New +$225K 0.07% 165

Other funds holding TMO

Ironwood Investment Counsel's TMO Position: Q2 2026 in Review

Ironwood Investment Counsel held its Thermo Fisher Scientific (TMO) position steady in Q2 2026 at 588 shares worth $295K. The position accounts for 0.04% of the portfolio, ranked #221.

Ironwood Investment Counsel first reported a position in TMO in Q2 2020 and has held it in 18 quarters since. The position peaked at $474K in Q1 2023. 1,512 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Ironwood Investment Counsel held 588 shares of Thermo Fisher Scientific worth $295K as of Q2 2026.
  • Ironwood Investment Counsel left its Thermo Fisher Scientific share count unchanged in Q2 2026.
  • Thermo Fisher Scientific made up 0.04% of Ironwood Investment Counsel's portfolio in Q2 2026, its #221 holding.
  • Ironwood Investment Counsel first reported a position in Thermo Fisher Scientific in Q2 2020 and has held it in 18 quarters since.
  • Ironwood Investment Counsel's Thermo Fisher Scientific position peaked at $474K in Q1 2023.
  • 1,512 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Ironwood Investment Counsel's 13F filing for Q2 2026, filed 6 Aug 2026.